The importance of hypoxia in disease pathogenesis and prognosis is gathering increasing
clinical significance and having a greater impact on patient management and outcome. …

The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients
with metastatic melanoma: a systematic review and meta-analysis | European Journal of …

Background Conventional imaging using CT and bone scan has insufficient sensitivity
when staging men with high-risk localised prostate cancer. We aimed to investigate whether …

Simple Summary Monoclonal antibodies (mAbs) have the ability to specifically target tumor-cell
antigens. This unique property has led to their use in the delivery of radioisotopes to …

Background Lutetium-177 [ 177 Lu]Lu-PSMA-617 is a radiolabelled small molecule that delivers
β radiation to cells expressing prostate-specific membrane antigen (PSMA), with activity …

Background Previously, results from the TheraP trial showed that treatment with lutetium-177
[ 177 Lu]Lu-PSMA-617 improved frequency of prostate-specific antigen (PSA) response …

Amyloid-β (Aβ) imaging with N-methyl- 11 C-2-(4′-methylamino-phenyl)-6-hydroxy-benzothiazole
( 11 C-6-OH-BTA-1; also known as 11 C-PIB) shows a robust increase in cortical …

Purpose We evaluated whether 18 F-FDG-PET altered stage classification, management,
and prognostic stratification of newly diagnosed small cell lung cancer (SCLC). Procedures …

Background. This study investigates the use of 18 F-fluoromisonidazole (FMISO) PET-guided
radiotherapy dose painting for potentially overcoming the radioresistant effects of hypoxia …

Immune evasion, due to abnormal expression of programmed-death ligands 1 and 2 (PD-L1/PD-L2),
predicts poor outcomes with chemoimmunotherapy in diffuse large B-cell …